“…The spliceosome is the active arrangement of small nuclear ribonucleoprotein particles (snRNPs), which aligns the splice site boundaries and serves as the catalytic machinery for splicing+ The relative efficiency of spliceosome assembly on multiple introns of a complex pre-mRNA is instrumental in determining patterns of alternative splicing, as well as the accuracy of individual splicing events+ Whether an internal exon is constitutively spliced or subject to exon skipping is determined by the strength of the individual splice sites flanking the exon in combination with the effects of splicing enhancer and/or repressor elements (Burge et al+, 1999;Smith & Valcarcel, 2000)+ Serine/argininerich (SR) protein splicing factors and hnRNP proteins, which in specific combinations interact with such regulatory elements, have been shown to exhibit some tissue-specific variations (Kamma et al+, 1995;Hanamura et al+, 1998)+ However, these previous studies do not reveal a striking pattern of enrichment, or deficiency, of these factors in nervous system tissue, leaving open the possibility that subtle combinatorial differences in these proteins may contribute to splicing regulation in many tissues+ A number of RNA-binding proteins have been implicated in the regulation of neural-specific splicing events+ Nova-1 is a splicing activator with three hnRNP K homology (KH) domains, and its expression pattern is brain specific (Buckanovich et al+, 1996;Buckanovich & Darnell, 1997)+ Targets of Nova-1 regulation include the neural exons of the GlyRa2 and GABA A receptor g2 transcripts, which are positively regulated in transient coexpression assays (Jensen et al+, 2000a(Jensen et al+, , 2000b)+ In Nova-1 knockout mice, the ratio of the exon-included and exon-skipped mRNA products is disrupted in the corresponding midbrain and hindbrain regions where Nova-1 protein has been genetically depleted+…”